Good Pharmacovigilance Practice modules released by European Medicine Agency

pharmafile | March 1, 2012 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV 

The European Medicines Agency has now released drafts of the first seven Good Pharmacovigilance Practice (GPvP) Modules for public consultation.  These modules are a key deliverable of the updated pharmacovigilance legislation which will apply from July 2012. 

If you require assistance in understanding these, the further Modules yet to be released or interpreting what the implications are for your pharmacovigilance system, our consultants at Wainwright Associates will be pleased to discuss.  Please contact us via e-mail enquiries@wainwrightassociates.co.uk or telephone +44 (0)1628 530554.
 
Visit www.wainwrightassociates.co.uk

Related Content

EMA request feedback on the draft EU reference dates

The European Medicines Agency has invited marketing-authorisation holders and other stakeholders to review and provide …

Updated set of mandatory Article 57(2) requirements for marketing authorisation holders

An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article …

Latest content